Skip to main content
Erschienen in: Current Treatment Options in Oncology 5/2017

01.05.2017 | Head and Neck Cancer (L Licitra, Section Editor)

Quality of Life Measurements: Any Value for Clinical Practice?

verfasst von: Matthias Büttner, MSc, Veit Zebralla, MD, Andreas Dietz, MD, Susanne Singer, PhD

Erschienen in: Current Treatment Options in Oncology | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Opinion statement

Quality of life measurements are well established in cancer clinical trials. In daily clinical practice, where cancer patients often suffer from disease-specific symptoms and report unmet needs regarding their treatment, these measurements are not systematically implemented. The systematic (often computer-based) assessment of quality of life in daily cancer care has shown to be beneficial for patient-physician communication, symptom management, shared decision-making, and in creating a learning health system. Unfortunately, to date, routine electronic quality of life assessments are usually limited to large cancer facilities. Patient and physician barriers as well as barriers from the administrative side in particular are currently hindering the implementation of these systems into the broad spectrum of clinical cancer care. Cost-effectiveness analyses of existing systems, the inclusion of all relevant stakeholders, and clear implementation guidelines are required to introduce quality of life measurements in clinical cancer practice to improve the treatment of cancer survivors and to create a health care system that addresses all their disease-related needs.
Literatur
1.
Zurück zum Zitat Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271–89.CrossRefPubMed Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271–89.CrossRefPubMed
2.
Zurück zum Zitat DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252–71.CrossRefPubMed DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252–71.CrossRefPubMed
3.
Zurück zum Zitat Bottomley A, Aaronson NK, European organisation for R and treatment of C. International perspective on health-related quality-of-life research in cancer clinical trials: the European Organisation for Research and Treatment of Cancer experience. J Clin Oncol. 2007;25(32):5082–6.CrossRefPubMed Bottomley A, Aaronson NK, European organisation for R and treatment of C. International perspective on health-related quality-of-life research in cancer clinical trials: the European Organisation for Research and Treatment of Cancer experience. J Clin Oncol. 2007;25(32):5082–6.CrossRefPubMed
4.
Zurück zum Zitat Henry DH, Viswanathan HN, Elkin EP, Traina S, Wade S, Cella D. Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. Support Care Cancer. 2008;16(7):791–801.CrossRefPubMed Henry DH, Viswanathan HN, Elkin EP, Traina S, Wade S, Cella D. Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. Support Care Cancer. 2008;16(7):791–801.CrossRefPubMed
5.
Zurück zum Zitat Kangas M, Henry JL, Bryant RA. The course of psychological disorders in the 1st year after cancer diagnosis. J Consult Clin Psychol. 2005;73(4):763–8.CrossRefPubMed Kangas M, Henry JL, Bryant RA. The course of psychological disorders in the 1st year after cancer diagnosis. J Consult Clin Psychol. 2005;73(4):763–8.CrossRefPubMed
6.
Zurück zum Zitat Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer. 2008;112(11 Suppl):2577–92.CrossRefPubMed Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer. 2008;112(11 Suppl):2577–92.CrossRefPubMed
7.
Zurück zum Zitat de Graeff A, de Leeuw JR, Ros WJ, Hordijk GJ, Blijham GH, Winnubst JA. Long-term quality of life of patients with head and neck cancer. Laryngoscope. 2000;110(1):98–106.CrossRefPubMed de Graeff A, de Leeuw JR, Ros WJ, Hordijk GJ, Blijham GH, Winnubst JA. Long-term quality of life of patients with head and neck cancer. Laryngoscope. 2000;110(1):98–106.CrossRefPubMed
8.
Zurück zum Zitat Verdonck-de Leeuw IM, Eerenstein SE, Van der Linden MH, Kuik DJ, de Bree R, Leemans CR. Distress in spouses and patients after treatment for head and neck cancer. Laryngoscope. 2007;117(2):238–41.CrossRefPubMed Verdonck-de Leeuw IM, Eerenstein SE, Van der Linden MH, Kuik DJ, de Bree R, Leemans CR. Distress in spouses and patients after treatment for head and neck cancer. Laryngoscope. 2007;117(2):238–41.CrossRefPubMed
9.
Zurück zum Zitat de Bree R, Verdonck-de Leeuw IM, Keizer AL, Houffelaar A, Leemans CR. Touch screen computer-assisted health-related quality of life and distress data collection in head and neck cancer patients. Clin Otolaryngol. 2008;33(2):138–42.CrossRefPubMed de Bree R, Verdonck-de Leeuw IM, Keizer AL, Houffelaar A, Leemans CR. Touch screen computer-assisted health-related quality of life and distress data collection in head and neck cancer patients. Clin Otolaryngol. 2008;33(2):138–42.CrossRefPubMed
10.
Zurück zum Zitat Verdonck-de Leeuw IM, de Bree R, Keizer AL, Houffelaar T, Cuijpers P, van der Linden MH, et al. Computerized prospective screening for high levels of emotional distress in head and neck cancer patients and referral rate to psychosocial care. Oral Oncol. 2009;45(10):e129–33.CrossRefPubMed Verdonck-de Leeuw IM, de Bree R, Keizer AL, Houffelaar T, Cuijpers P, van der Linden MH, et al. Computerized prospective screening for high levels of emotional distress in head and neck cancer patients and referral rate to psychosocial care. Oral Oncol. 2009;45(10):e129–33.CrossRefPubMed
11.
Zurück zum Zitat Sollner W, DeVries A, Steixner E, Lukas P, Sprinzl G, Rumpold G, et al. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? Br J Cancer. 2001;84(2):179–85.CrossRefPubMedPubMedCentral Sollner W, DeVries A, Steixner E, Lukas P, Sprinzl G, Rumpold G, et al. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? Br J Cancer. 2001;84(2):179–85.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Rose M, Bezjak A. Logistics of collecting patient-reported outcomes (PROs) in clinical practice: an overview and practical examples. Qual Life Res. 2009;18(1):125–36.CrossRefPubMed Rose M, Bezjak A. Logistics of collecting patient-reported outcomes (PROs) in clinical practice: an overview and practical examples. Qual Life Res. 2009;18(1):125–36.CrossRefPubMed
14.
Zurück zum Zitat Trautmann F, Hentschel L, Hornemann B, Rentsch A, Baumann M, Ehninger G, et al. Electronic real-time assessment of patient-reported outcomes in routine care-first findings and experiences from the implementation in a comprehensive cancer center. Support Care Cancer. 2016;24(7):3047–56.PubMed Trautmann F, Hentschel L, Hornemann B, Rentsch A, Baumann M, Ehninger G, et al. Electronic real-time assessment of patient-reported outcomes in routine care-first findings and experiences from the implementation in a comprehensive cancer center. Support Care Cancer. 2016;24(7):3047–56.PubMed
15.
Zurück zum Zitat Kuijpers W, Giesinger JM, Zabernigg A, Young T, Friend E, Tomaszewska IM, et al. Patients' and health professionals' understanding of and preferences for graphical presentation styles for individual-level EORTC QLQ-C30 scores. Qual Life Res. 2016;25(3):595–604.CrossRefPubMed Kuijpers W, Giesinger JM, Zabernigg A, Young T, Friend E, Tomaszewska IM, et al. Patients' and health professionals' understanding of and preferences for graphical presentation styles for individual-level EORTC QLQ-C30 scores. Qual Life Res. 2016;25(3):595–604.CrossRefPubMed
16.
Zurück zum Zitat Atkinson TM, Ryan SJ, Bennett AV, Stover AM, Saracino RM, Rogak LJ, et al. The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review. Support Care Cancer. 2016;24(8):3669–76.CrossRefPubMed Atkinson TM, Ryan SJ, Bennett AV, Stover AM, Saracino RM, Rogak LJ, et al. The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review. Support Care Cancer. 2016;24(8):3669–76.CrossRefPubMed
17.
Zurück zum Zitat Dueck AC, Mendoza TR, Mitchell SA, Reeve BB, Castro KM, Rogak LJ, et al. Validity and reliability of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). JAMA Oncol. 2015;1(8):1051–9.CrossRefPubMedPubMedCentral Dueck AC, Mendoza TR, Mitchell SA, Reeve BB, Castro KM, Rogak LJ, et al. Validity and reliability of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). JAMA Oncol. 2015;1(8):1051–9.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Chen J, Ou L, Hollis SJ. A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting. BMC Health Serv Res. 2013;13:211.CrossRefPubMedPubMedCentral Chen J, Ou L, Hollis SJ. A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting. BMC Health Serv Res. 2013;13:211.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Hilarius DL, Kloeg PH, Gundy CM, Aaronson NK. Use of health-related quality-of-life assessments in daily clinical oncology nursing practice: a community hospital-based intervention study. Cancer. 2008;113(3):628–37.CrossRefPubMed Hilarius DL, Kloeg PH, Gundy CM, Aaronson NK. Use of health-related quality-of-life assessments in daily clinical oncology nursing practice: a community hospital-based intervention study. Cancer. 2008;113(3):628–37.CrossRefPubMed
20.
Zurück zum Zitat Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA. 2002;288(23):3027–34.CrossRefPubMed Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA. 2002;288(23):3027–34.CrossRefPubMed
21.
Zurück zum Zitat Velikova G, Booth L, Smith AB, Brown PM, Lynch P, Brown JM, et al. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol. 2004;22(4):714–24.CrossRefPubMed Velikova G, Booth L, Smith AB, Brown PM, Lynch P, Brown JM, et al. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol. 2004;22(4):714–24.CrossRefPubMed
22.
Zurück zum Zitat Duman-Lubberding S, van Uden-Kraan CF, Peek N, Cuijpers P, Leemans CR, Verdonck-de Leeuw IM. An eHealth application in head and neck cancer survivorship care: health care professionals' perspectives. J Med Internet Res. 2015;17(10):e235.CrossRefPubMedPubMedCentral Duman-Lubberding S, van Uden-Kraan CF, Peek N, Cuijpers P, Leemans CR, Verdonck-de Leeuw IM. An eHealth application in head and neck cancer survivorship care: health care professionals' perspectives. J Med Internet Res. 2015;17(10):e235.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Jansen F, van Uden-Kraan CF, van Zwieten V, Witte BI, Verdonck-de Leeuw IM. Cancer survivors' perceived need for supportive care and their attitude towards self-management and eHealth. Support Care Cancer. 2015;23(6):1679–88.CrossRefPubMed Jansen F, van Uden-Kraan CF, van Zwieten V, Witte BI, Verdonck-de Leeuw IM. Cancer survivors' perceived need for supportive care and their attitude towards self-management and eHealth. Support Care Cancer. 2015;23(6):1679–88.CrossRefPubMed
24.
Zurück zum Zitat So WK, Choi KC, Chen JM, Chan CW, Chair SY, Fung OW, et al. Quality of life in head and neck cancer survivors at 1 year after treatment: the mediating role of unmet supportive care needs. Support Care Cancer. 2014;22(11):2917–26.CrossRefPubMed So WK, Choi KC, Chen JM, Chan CW, Chair SY, Fung OW, et al. Quality of life in head and neck cancer survivors at 1 year after treatment: the mediating role of unmet supportive care needs. Support Care Cancer. 2014;22(11):2917–26.CrossRefPubMed
25.
Zurück zum Zitat Abernethy AP, Herndon 2nd JE, Wheeler JL, Day JM, Hood L, Patwardhan M, et al. Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: pilot study of an e/tablet data-collection system in academic oncology. J Pain Symptom Manag. 2009;37(6):1027–38.CrossRef Abernethy AP, Herndon 2nd JE, Wheeler JL, Day JM, Hood L, Patwardhan M, et al. Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: pilot study of an e/tablet data-collection system in academic oncology. J Pain Symptom Manag. 2009;37(6):1027–38.CrossRef
26.
Zurück zum Zitat Kane HL, Halpern MT, Squiers LB, Treiman KA, McCormack LA. Implementing and evaluating shared decision making in oncology practice. CA Cancer J Clin. 2014;64(6):377–88.CrossRefPubMed Kane HL, Halpern MT, Squiers LB, Treiman KA, McCormack LA. Implementing and evaluating shared decision making in oncology practice. CA Cancer J Clin. 2014;64(6):377–88.CrossRefPubMed
27.
Zurück zum Zitat Velikova G, Keding A, Harley C, Cocks K, Booth L, Smith AB, et al. Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: secondary outcomes of a randomised controlled trial. Eur J Cancer. 2010;46(13):2381–8.CrossRefPubMed Velikova G, Keding A, Harley C, Cocks K, Booth L, Smith AB, et al. Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: secondary outcomes of a randomised controlled trial. Eur J Cancer. 2010;46(13):2381–8.CrossRefPubMed
28.
Zurück zum Zitat Snyder CF, Jensen R, Courtin SO, Wu AW. Website for outpatient QOLARN. PatientViewpoint: a website for patient-reported outcomes assessment. Qual Life Res. 2009;18(7):793–800.CrossRefPubMedPubMedCentral Snyder CF, Jensen R, Courtin SO, Wu AW. Website for outpatient QOLARN. PatientViewpoint: a website for patient-reported outcomes assessment. Qual Life Res. 2009;18(7):793–800.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Kotronoulas G, Kearney N, Maguire R, Harrow A, Di Domenico D, Croy S, et al. What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol. 2014;32(14):1480–501.CrossRefPubMed Kotronoulas G, Kearney N, Maguire R, Harrow A, Di Domenico D, Croy S, et al. What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol. 2014;32(14):1480–501.CrossRefPubMed
30.
Zurück zum Zitat Lubberding S, van Uden-Kraan CF, Te Velde EA, Cuijpers P, Leemans CR, Verdonck-de Leeuw IM. Improving access to supportive cancer care through an eHealth application: a qualitative needs assessment among cancer survivors. J Clin Nurs. 2015;24(9–10):1367–79.CrossRefPubMed Lubberding S, van Uden-Kraan CF, Te Velde EA, Cuijpers P, Leemans CR, Verdonck-de Leeuw IM. Improving access to supportive cancer care through an eHealth application: a qualitative needs assessment among cancer survivors. J Clin Nurs. 2015;24(9–10):1367–79.CrossRefPubMed
31.
Zurück zum Zitat Giesinger J, Kemmler G, Meraner V, Gamper EM, Oberguggenberger A, Sperner-Unterweger B, et al. Towards the implementation of quality of life monitoring in daily clinical routine: methodological issues and clinical implication. Breast Care (Basel). 2009;4(3):148–54.CrossRef Giesinger J, Kemmler G, Meraner V, Gamper EM, Oberguggenberger A, Sperner-Unterweger B, et al. Towards the implementation of quality of life monitoring in daily clinical routine: methodological issues and clinical implication. Breast Care (Basel). 2009;4(3):148–54.CrossRef
32.
Zurück zum Zitat Wu AW, White SM, Blackford AL, Wolff AC, Carducci MA, Herman JM, et al. Improving an electronic system for measuring PROs in routine oncology practice. J Cancer Surviv. 2016;10(3):573–82.CrossRefPubMed Wu AW, White SM, Blackford AL, Wolff AC, Carducci MA, Herman JM, et al. Improving an electronic system for measuring PROs in routine oncology practice. J Cancer Surviv. 2016;10(3):573–82.CrossRefPubMed
33.
Zurück zum Zitat Brundage MD, Smith KC, Little EA, Bantug ET, Snyder CF, Board PRODPSA. Communicating patient-reported outcome scores using graphic formats: results from a mixed-methods evaluation. Qual Life Res. 2015;24(10):2457–72.CrossRefPubMedPubMedCentral Brundage MD, Smith KC, Little EA, Bantug ET, Snyder CF, Board PRODPSA. Communicating patient-reported outcome scores using graphic formats: results from a mixed-methods evaluation. Qual Life Res. 2015;24(10):2457–72.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Boyce MB, Browne JP, Greenhalgh J. The experiences of professionals with using information from patient-reported outcome measures to improve the quality of healthcare: a systematic review of qualitative research. BMJ Qual Saf. 2014;23(6):508–18.CrossRefPubMed Boyce MB, Browne JP, Greenhalgh J. The experiences of professionals with using information from patient-reported outcome measures to improve the quality of healthcare: a systematic review of qualitative research. BMJ Qual Saf. 2014;23(6):508–18.CrossRefPubMed
35.
Zurück zum Zitat Jagsi R, Chiang A, Polite BN, Medeiros BC, McNiff K, Abernethy AP, et al. Qualitative analysis of practicing oncologists' attitudes and experiences regarding collection of patient-reported outcomes. J Oncol Pract. 2013;9(6):e290–7.CrossRefPubMed Jagsi R, Chiang A, Polite BN, Medeiros BC, McNiff K, Abernethy AP, et al. Qualitative analysis of practicing oncologists' attitudes and experiences regarding collection of patient-reported outcomes. J Oncol Pract. 2013;9(6):e290–7.CrossRefPubMed
37.
Zurück zum Zitat Davis K, Cella D. Assessing quality of life in oncology clinical practice: a review of barriers and critical Sucess factors. JCOM. 2002;9:327–32. Davis K, Cella D. Assessing quality of life in oncology clinical practice: a review of barriers and critical Sucess factors. JCOM. 2002;9:327–32.
38.
Zurück zum Zitat Duman-Lubberding S, van Uden-Kraan CF, Jansen F, Witte BI, van der Velden LA, Lacko M, et al. Feasibility of an eHealth application "OncoKompas" to improve personalized survivorship cancer care. Support Care Cancer. 2016;24(5):2163–71.CrossRefPubMed Duman-Lubberding S, van Uden-Kraan CF, Jansen F, Witte BI, van der Velden LA, Lacko M, et al. Feasibility of an eHealth application "OncoKompas" to improve personalized survivorship cancer care. Support Care Cancer. 2016;24(5):2163–71.CrossRefPubMed
39.
Zurück zum Zitat Wintner LM, Giesinger JM, Zabernigg A, Rumpold G, Sztankay M, Oberguggenberger AS, et al. Evaluation of electronic patient-reported outcome assessment with cancer patients in the hospital and at home. BMC Med Inform Decis Mak. 2015;15:110.CrossRefPubMedPubMedCentral Wintner LM, Giesinger JM, Zabernigg A, Rumpold G, Sztankay M, Oberguggenberger AS, et al. Evaluation of electronic patient-reported outcome assessment with cancer patients in the hospital and at home. BMC Med Inform Decis Mak. 2015;15:110.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Bush N, Donaldson G, Moinpour C, Haberman M, Milliken D, Markle V, et al. Development, feasibility and compliance of a web-based system for very frequent QOL and symptom home self-assessment after hematopoietic stem cell transplantation. Qual Life Res. 2005;14(1):77–93.CrossRefPubMed Bush N, Donaldson G, Moinpour C, Haberman M, Milliken D, Markle V, et al. Development, feasibility and compliance of a web-based system for very frequent QOL and symptom home self-assessment after hematopoietic stem cell transplantation. Qual Life Res. 2005;14(1):77–93.CrossRefPubMed
41.
Zurück zum Zitat •• Jensen RE, Snyder CF, Abernethy AP, Basch E, Potosky AL, Roberts AC, et al. Review of electronic patient-reported outcomes systems used in cancer clinical care. J Oncol Pract. 2014;10(4):e215–22. A systemic review that identified the currently existing electronic patient-report outcomes systems in clinical cancer care and described features and barriers of those systems.CrossRefPubMed •• Jensen RE, Snyder CF, Abernethy AP, Basch E, Potosky AL, Roberts AC, et al. Review of electronic patient-reported outcomes systems used in cancer clinical care. J Oncol Pract. 2014;10(4):e215–22. A systemic review that identified the currently existing electronic patient-report outcomes systems in clinical cancer care and described features and barriers of those systems.CrossRefPubMed
42.
Zurück zum Zitat Stover A, Irwin DE, Chen RC, Chera BS, Mayer DK, Muss HB, et al. Integrating patient-reported outcome measures into routine cancer care: cancer Patients' and Clinicians' perceptions of acceptability and value. EGEMS (Wash DC). 2015;3(1):1169. Stover A, Irwin DE, Chen RC, Chera BS, Mayer DK, Muss HB, et al. Integrating patient-reported outcome measures into routine cancer care: cancer Patients' and Clinicians' perceptions of acceptability and value. EGEMS (Wash DC). 2015;3(1):1169.
43.
Zurück zum Zitat Howell D, Molloy S, Wilkinson K, Green E, Orchard K, Wang K, et al. Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors. Ann Oncol. 2015;26(9):1846–58.CrossRefPubMed Howell D, Molloy S, Wilkinson K, Green E, Orchard K, Wang K, et al. Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors. Ann Oncol. 2015;26(9):1846–58.CrossRefPubMed
44.
Zurück zum Zitat Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557–65.CrossRefPubMed Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557–65.CrossRefPubMed
45.
Zurück zum Zitat Shah A, Stewart AK, Kolacevski A, Michels D, Miller R. Building a rapid learning health care system for oncology: why CancerLinQ collects identifiable health information to achieve its vision. J Clin Oncol. 2016;34(7):756–63.CrossRefPubMed Shah A, Stewart AK, Kolacevski A, Michels D, Miller R. Building a rapid learning health care system for oncology: why CancerLinQ collects identifiable health information to achieve its vision. J Clin Oncol. 2016;34(7):756–63.CrossRefPubMed
46.
Zurück zum Zitat Abernethy AP, Ahmad A, Zafar SY, Wheeler JL, Reese JB, Lyerly HK. Electronic patient-reported data capture as a foundation of rapid learning cancer care. Med Care. 2010;48(6 Suppl):S32–8.CrossRefPubMed Abernethy AP, Ahmad A, Zafar SY, Wheeler JL, Reese JB, Lyerly HK. Electronic patient-reported data capture as a foundation of rapid learning cancer care. Med Care. 2010;48(6 Suppl):S32–8.CrossRefPubMed
47.
Zurück zum Zitat Broering JM, Paciorek A, Carroll PR, Wilson LS, Litwin MS, Miaskowski C. Measurement equivalence using a mixed-mode approach to administer health-related quality of life instruments. Qual Life Res. 2014;23(2):495–508.CrossRefPubMed Broering JM, Paciorek A, Carroll PR, Wilson LS, Litwin MS, Miaskowski C. Measurement equivalence using a mixed-mode approach to administer health-related quality of life instruments. Qual Life Res. 2014;23(2):495–508.CrossRefPubMed
48.
Zurück zum Zitat McCleary NJ, Wigler D, Berry D, Sato K, Abrams T, Chan J, et al. Feasibility of computer-based self-administered cancer-specific geriatric assessment in older patients with gastrointestinal malignancy. Oncologist. 2013;18(1):64–72.CrossRefPubMedPubMedCentral McCleary NJ, Wigler D, Berry D, Sato K, Abrams T, Chan J, et al. Feasibility of computer-based self-administered cancer-specific geriatric assessment in older patients with gastrointestinal malignancy. Oncologist. 2013;18(1):64–72.CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat Gencer D, Tauchert F, Keilhauer N, Al-Batran SE, Stahl M, Oskay-Ozcelik G, et al. Cancer patients and the Internet: a survey of the 'Quality of Life' working groups of the Arbeitsgemeinschaft fur Internistische Onkologie and the Nord-Ostdeutsche Gesellschaft fur Gynakologische Onkologie. Onkologie. 2011;34(8–9):435–40.CrossRefPubMed Gencer D, Tauchert F, Keilhauer N, Al-Batran SE, Stahl M, Oskay-Ozcelik G, et al. Cancer patients and the Internet: a survey of the 'Quality of Life' working groups of the Arbeitsgemeinschaft fur Internistische Onkologie and the Nord-Ostdeutsche Gesellschaft fur Gynakologische Onkologie. Onkologie. 2011;34(8–9):435–40.CrossRefPubMed
50.
Zurück zum Zitat Snyder CF, Herman JM, White SM, Luber BS, Blackford AL, Carducci MA, et al. When using patient-reported outcomes in clinical practice, the measure matters: a randomized controlled trial. J Oncol Pract. 2014;10(5):e299–306.CrossRefPubMedPubMedCentral Snyder CF, Herman JM, White SM, Luber BS, Blackford AL, Carducci MA, et al. When using patient-reported outcomes in clinical practice, the measure matters: a randomized controlled trial. J Oncol Pract. 2014;10(5):e299–306.CrossRefPubMedPubMedCentral
52.
Zurück zum Zitat Tschiesner U, Linseisen E, Baumann S, Siedek V, Stelter K, Berghaus A, et al. Assessment of functioning in patients with head and neck cancer according to the International Classification of Functioning, Disability, and Health (ICF): a multicenter study. Laryngoscope. 2009;119(5):915–23.CrossRefPubMed Tschiesner U, Linseisen E, Baumann S, Siedek V, Stelter K, Berghaus A, et al. Assessment of functioning in patients with head and neck cancer according to the International Classification of Functioning, Disability, and Health (ICF): a multicenter study. Laryngoscope. 2009;119(5):915–23.CrossRefPubMed
53.
Zurück zum Zitat Tschiesner U, Rogers S, Dietz A, Yueh B, Cieza A. Development of ICF core sets for head and neck cancer. Head Neck. 2010;32(2):210–20.PubMed Tschiesner U, Rogers S, Dietz A, Yueh B, Cieza A. Development of ICF core sets for head and neck cancer. Head Neck. 2010;32(2):210–20.PubMed
54.
Zurück zum Zitat Tschiesner U, Stier-Jarmer M, Strieth S, Singer S, Dietz A, Fietkau R, et al. Development of an ICF-based clinical practice guideline for the assessment of function in head and neck cancer. Laryngo- rhino- otologie. 2013;92(5):314–25.CrossRefPubMed Tschiesner U, Stier-Jarmer M, Strieth S, Singer S, Dietz A, Fietkau R, et al. Development of an ICF-based clinical practice guideline for the assessment of function in head and neck cancer. Laryngo- rhino- otologie. 2013;92(5):314–25.CrossRefPubMed
Metadaten
Titel
Quality of Life Measurements: Any Value for Clinical Practice?
verfasst von
Matthias Büttner, MSc
Veit Zebralla, MD
Andreas Dietz, MD
Susanne Singer, PhD
Publikationsdatum
01.05.2017
Verlag
Springer US
Erschienen in
Current Treatment Options in Oncology / Ausgabe 5/2017
Print ISSN: 1527-2729
Elektronische ISSN: 1534-6277
DOI
https://doi.org/10.1007/s11864-017-0470-4

Weitere Artikel der Ausgabe 5/2017

Current Treatment Options in Oncology 5/2017 Zur Ausgabe

Genitourinary Cancers (W Oh and M Galsky, Section Editors)

Management Options for Biochemically Recurrent Prostate Cancer

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.